Kimberly Manhard, Director at Inhibrx Biosciences, Inc. (INBX), bought 10,000 shares at $13.98 ($140K) on 2024-08-28, disclosed to the SEC on 2024-08-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| HRTX | SELL | 2022-05-04 | $7K | — | Filing → |
| HRTX | SELL | 2021-05-04 | $27K | — | Filing → |
| HRTX | SELL | 2020-12-23 | $200K | — | Filing → |